Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Selective iNOS inhibitor protects against IL-1beta-induced rat pancreatic islet damage

Sep. 13, 2001

GSK3 inhibitor CT-98023 targets glucose intolerance and insulin resistance of type 2 diabetes

Sep. 13, 2001

KRX-101 granted fast track status by FDA as treatment for diabetic nephropathy

Sep. 13, 2001

LGD-2226 selected as clinical candidate SARM

Sep. 12, 2001

Selective cathepsin K inhibitors synthesized and tested at Roche

Sep. 12, 2001

Long-term clinical data favor rosuvastatin over other statins in hypercholesterolemia

Sep. 12, 2001

Proof of concept established in phase II trials for NN-622

Sep. 12, 2001

FDA accepts Estrasorb NDA for review

Sep. 12, 2001

Data from first study in female Fabry's disease patients discussed at recent workshop

Sep. 10, 2001

Glucose excursion decreased, formation of new beta-cells enhanced by DPP IV inhibitor

Sep. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.